NCT02246725 2025-09-12
ALLAN
Lund University Hospital
Completed
Clinical Trials
32 trialsNCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT04659590 2024-10-18
ORI-EGI-02
Origin Sciences
Completed
NCT06435975 2024-05-30
Physical Activity in Rectal Cancer Survivors
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT02831556 2024-05-21
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Duke University
Completed
NCT03559543 2024-02-07
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT04134104 2023-11-13
Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy
National Academy of Medical Sciences, Nepal
Completed
NCT05605600 2023-04-05
Translation of the International Consensus Definition of LARS Into a Bowl Dysfunction Severity Scoring Tool (New LARS Score)
Cardiff and Vale University Health Board
Completed
NCT04080843 2022-07-13
ALTER-C-002
Zhejiang University
Phase 2 Completed
NCT01966289 2021-03-30
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03723447 2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4 Completed
NCT02981524 2021-02-10
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04733794 2021-02-03
Feasibility Bowel Dysfunction Program After Low Anterior Resection
Fox Chase Cancer Center
Phase NA Completed
NCT04287335 2020-12-08
CLEAR-C
Zhejiang University
Completed
NCT01397305 2020-09-09
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT03920202 2019-04-18
LongLARS
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Completed
NCT02785783 2019-02-04
Erings™
Portsmouth Hospitals NHS Trust
Phase NA Completed
NCT03072472 2018-09-06
B-ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Phase NA Completed
NCT00241722 2017-08-30
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01177007 2017-08-28
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Phase 2 Completed
NCT02141945 2017-03-28
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Corp
Completed
NCT01819766 2017-02-17
OCEANIA
Exact Sciences Corporation
Completed
NCT02503696 2016-08-10
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
Exact Sciences Corporation
Completed
NCT01397747 2015-12-03
DeeP-C
Exact Sciences Corporation
Completed
NCT00135577 2015-09-02
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00256932 2015-09-02
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT00259922 2015-09-02
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01269567 2015-07-23
GRECCAR 5
University Hospital, Bordeaux
Phase 3 Completed
NCT01260168 2015-05-13
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Exact Sciences Corporation
Completed
NCT01600209 2015-05-13
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Exact Sciences Corporation
Completed
NCT00808743 2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3 Completed